Parakkal Deepak

Parakkal Deepak, MBBS, MS, FACG, is currently a Physician-Scientist at the Inflammatory Bowel Disease (IBD) Center in the Division of Gastroenterology at the Washington University School of Medicine (WUSM) in St. Louis, Missouri where he also is an Associate Professor of Medicine and Director of Clinical and Translation Research.

He is a Fellow of the American College of Gastroenterology (ACG) and has been recognized as a ‘AGA Future Leader’ by the American Gastroenterological Association. He has been funded by the American College of Gastroenterology Junior Faculty Development Award, the American Gastroenterological Association, and The Leona M. and Harry B. Helmsley Charitable Trust apart from investigator-initiated grants funded by industry.

His group’s primary focus is on fistulizing perianal Crohn’s disease where he co-leads a bench-bedside basic-translational-clinical group focused on improving the precision of care in perianal CD through single cell work, radiomics and 3D print applications and is part of the international TOpCLASS Fistula Consortium. Additional focus area in research is cardiometabolic syndrome in IBD where his group has made novel observations in prevalence of NAFLD, risk of cirrhosis and performance of current ASCVD prediction tools in patients with IBD.

He has co-founded the REBOOT IBD Consortium across 11 leading IBD centers in the United States to publish real-world data on outcomes with newest advanced therapies in IBD. He serves as the Deputy Director of Data Quality and Enhancement of the prospective longitudinal biobanking cohort, the SPARC-IBD of the Crohn’s and Colitis Foundation.